title: Pyrimidine pathways in health and disease.
abstract: Genetic defects involving enzymes essential for pyrimidine nucleotide metabolism have provided new insights into the vital physiological functions of these molecules in addition to nucleic acid synthesis. Such aberrations disrupt the haematological, nervous or mitochondrial systems and can cause adverse reactions to analogue therapy. Regulation of pyrimidine pathways is also known to be disrupted in malignancies. Nine genetic defects have now been identified but only one is currently treatable. Diagnosis is aided by the accumulation of specific metabolites. Recently, progress has been made in understanding the molecular mechanisms underlying inborn errors of pyrimidine metabolism, together with the key clinical issues and the implications for the future development of novel drugs and therapeutic strategies.
authors.affiliation: Institute for Physiological Chemistry, Philipps-University, Marburg, Germany.
authors.forename: Monika
authors.initials: M
authors.lastname: Löffler
authors.forename: Lynette D
authors.initials: LD
authors.lastname: Fairbanks
authors.forename: Elke
authors.initials: E
authors.lastname: Zameitat
authors.forename: Anthony M
authors.initials: AM
authors.lastname: Marinaki
authors.forename: H Anne
authors.initials: HA
authors.lastname: Simmonds
mesh_terms: D006262:Health; D006801:Humans; D011686:Purine-Pyrimidine Metabolism, Inborn Errors / Q000175:diagnosis / Q000235:genetics / Q000378:metabolism* / Q000628:therapy; D011743:Pyrimidines / Q000037:antagonists & inhibitors / Q000378:metabolism*; D015398:Signal Transduction
chemical_list: D011743:Pyrimidines; C030986:pyrimidine